生物
再灌注损伤
缺血
小RNA
药理学
细胞生物学
内科学
生物化学
基因
医学
作者
Bicheng Fu,Jilu Lang,Dongyang Zhang,Lu Sun,Wei Chen,Wei Liu,Kai-Yu Liu,Chongyi Ma,Shulin Jiang,Ren‐Ke Li,Hai Tian
出处
期刊:Stem Cells and Development
[Mary Ann Liebert, Inc.]
日期:2017-06-09
卷期号:26 (17): 1270-1282
被引量:42
标识
DOI:10.1089/scd.2017.0062
摘要
MicroRNA-34a (miR-34a) is expressed in the myocardium and expression is altered after myocardial injury. We investigated the effects of miR-34a on heart function after ischemia-reperfusion (IR) injury. Cardiomyocytes were isolated from neonatal rat hearts and simulated IR injury was induced in vitro. Following IR injury in rats, infarct size was measured and left ventricular (LV) function was evaluated using echocardiography. Protein expression of silent information regulator 1 (SIRT1), acetylated p53 (ac-p53), Bcl-2 and Bax, and miR-34a and SIRT1 gene levels were analyzed. miR-34a overexpression exacerbated myocardial injury by increasing apoptosis and infarct size and decreasing LV function. Suppression of miR-34a attenuated myocardial IR injury. SIRT1 was negatively regulated by miR-34a and the expression of downstream genes, such as ac-p53, Bcl-2, and Bax were altered correspondingly. Increased expression of miR-34a aggravates injury after IR; miR-34a suppression therapy may represent a new line of treatment for myocardial IR injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI